Background And Aims: Previous studies reported significant variation in the management of patients with Barrett's esophagus. However, these are based on self-reported clinical practice. The aim of this study was to examine the management of high-grade dysplasia in Barrett's esophagus in England by using patient-level data and to compare practice with guidelines.
View Article and Find Full Text PDFObjectives: Palliative chemotherapy is routinely given to patients diagnosed with locally advanced or metastatic oesophagogastric (O-G) cancer. We examine which patients with O-G cancer in England receive palliative chemotherapy, and identify factors associated with treatment completion.
Design: A prospective population-based observational study.
Background & Aims: Single-center studies have estimated that 4.6% to 25.8% of gastric cancers are missed at endoscopy.
View Article and Find Full Text PDFBackground: This study is an update on an earlier article in 2007 to assess the implementation of the Cancer Plan reform strategy in England and Wales.
Findings: A national online survey to upper gastro-intestinal leads at network and trust level. The questionnaire was designed based on existing clinical practice guidelines and addressed governing principles and operational procedures related to the delivery of cancer care.
Objective: To investigate the relationship between the route to diagnosis, patient characteristics, treatment intent and 1 -year survival among patients with oesophagogastric (O-G) cancer.
Setting: Cohort study in 142 English NHS trusts and 30 cancer networks.
Participants: Patients diagnosed with O-G cancer between October 2007 and June 2009.
Background: Oesophago-gastric cancer services in England have been extensively reorganised since 2001 to deliver a centralised, specialist-led service. Our aim was to assess how well the National Health Service (NHS) in England met organisational standards for oesophago-gastric cancer care.
Methods: Questionnaires that asked about the provision of staging investigations, curative and palliative treatments and key personnel were sent in September 2007 to the lead clinician for oesophago-gastric cancer at all 30 cancer networks and 156 NHS acute trusts in England.